A randomized study comparing Diamicron MR and Amaryl once daily in people with well-controlled Type 2 Diabetes Mellitus whose current therapy includes sulphonylurea therapy.
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Gliclazide (Primary) ; Glimepiride (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2009 New trial record